About Index Trending news
Lists
Pricing
Savara Pharmaceuticals

Savara Pharmaceuticals

Savara Pharmaceuticals

Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection inCystic Fibrosis

Elsewhere

Alexa global traffic share

01 Mar 2016
$20,000,000
Venture capital (Series C)

Savara Pharmaceuticals Closes $20M Series C Financing

FinSMEs
+1
06 Oct 2014
$10,000,000
Venture capital
Boutique investment bank
12 Jun 2014
$4,493,581
Debt financing
21 Mar 2013
$7,400,000
Venture capital (Series B)